Oxilan® is a radiographic contrast agent used in diagnostic imaging studies. The degree of contrast enhancement is directly related to the iodine content in the administered dose. Dependent on the iodine content, the osmolalities are 2.1 or 2.4 times that of plasma (285 mOsm/kg water).

Reno-30® is a radiopaque contrast agent indicated for retrograde or ascending pyelography. Retrograde pyelography does not include systemic administration of contrast media, so the risk of adverse reactions is extremely rare.

Reno-60® is radiopaque contrast agent with a wide range of indications. Reno-60 should be at body temperature when injected and may need to be warmed before use. Following intravascular injection, iodinated contrast materials are transported through the bloodstream to the kidneys and excreted by glomerular filtration.

Sinografin® (diatrizoate meglumine and iodipamide meglumine) is a contrast agent indicated for use in hysterosalpingography. Intrauterine used contrast agents have few known pharmacological effects. Most of the medium within the uterine cavity is discharged immediately after finishing of the procedure and the contrast medium retained is completely absorbed.

Ultravist® is an iodinated contrast agent with low osmolality and low viscosity, enabling ease of administration and rapid iodine delivery rate. Ultravist® is available in 4 concentrations. Introduced in Europe 1985 and in the US in 1995, Ultravist® is being used today in over 100 countries worldwide.
See also Low-Osmolar Contrast Media.